127 related articles for article (PubMed ID: 6760132)
1. [Evaluation of Picibanil as an adjuvant chemotherapeutic agent].
Porwit-Ksiazek A; Kozłowicz-Gudzińska I; Zborzil J
Nowotwory; 1982; 32(3):103-9. PubMed ID: 6760132
[No Abstract] [Full Text] [Related]
2. Multimodal therapy from stage-II breast cancer.
Edelstyn GA; Bates T; Brinkley D; Kitchen G; MacRae KD; Nicol NT; Spittle M; Wheeler T
Lancet; 1978 Nov; 2(8099):1092. PubMed ID: 82102
[No Abstract] [Full Text] [Related]
3. Treatment of early breast cancer.
Holland JF
Lancet; 1978 Nov; 2(8100):1148-9. PubMed ID: 82703
[No Abstract] [Full Text] [Related]
4. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
Cowan K; Lippman M
Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
[No Abstract] [Full Text] [Related]
5. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Heuson JC; Paridaens R
Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
[No Abstract] [Full Text] [Related]
6. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Lee JM; Abeloff MD; Lenhard RE; Baker RR
Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
[No Abstract] [Full Text] [Related]
7. [Immunomodulating effects of indomethacin in breast cancer].
Polevaia EB; Chikvashvili BSh; Kupin VI; Letiagin VP
Sov Med; 1987; (8):27-30. PubMed ID: 3423958
[No Abstract] [Full Text] [Related]
8. Short-course cyclical chemotherapy in advanced breast cancer.
Edelstyn GA; Bates T; Brinkley D; MacRae KD; Spittle MF; Wheeler T
Lancet; 1977 Mar; 1(8011):592. PubMed ID: 65673
[No Abstract] [Full Text] [Related]
9. Adriamycin, vincristine, cyclophosphamide and 5-fluorouracil (AVCF) compared with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in premenopausal breast carcinoma. Personal results.
Mathé G; Misset JL; Plagne R; Reizenstein P; Belpomme D; Le Mevel B; Guerrin J; Fumoleau P; Metz R; Delgado M
Drugs Exp Clin Res; 1986; 12(1-3):143-5. PubMed ID: 3525068
[TBL] [Abstract][Full Text] [Related]
10. Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: a randomized study.
Carmo-Pereira J; Costa FO; Henriques E
Eur J Cancer (1965); 1980 Dec; 16(12):1621-5. PubMed ID: 7014228
[No Abstract] [Full Text] [Related]
11. Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
Tranum BL; McDonald B; Thigpen T; Vaughn C; Wilson H; Maloney T; Costanzi J; Bickers J; el Mawli NG; Palmer R; Hoogstraten B; Heilburn L; Rasmusen S
Cancer; 1982 Mar; 49(5):835-9. PubMed ID: 7037152
[No Abstract] [Full Text] [Related]
12. Combination chemotherapy in disseminated carcinoma of the breast.
Kaufman S; Goldstein M
Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324
[No Abstract] [Full Text] [Related]
13. Immuno-chemotherapy of malignant lymphoma using OK-432, a streptococcal agent.
Kimura I; Ohnoshi T; Nakata Y; Takasugi K; Fujii M; Hayashi K; Kataoka M; Sato M; Nishihara R
Acta Med Okayama; 1979 Dec; 33(6):471-8. PubMed ID: 94239
[TBL] [Abstract][Full Text] [Related]
14. Multimodal therapy for histological stage-II breast cancer. Multicentre Breast Cancer Chemotherapy Group.
Lancet; 1977 Aug; 2(8034):396-7. PubMed ID: 70600
[No Abstract] [Full Text] [Related]
15. Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP).
Carmo-Pereira J; Costa FO; Henriques E
Cancer; 1981 Oct; 48(7):1517-21. PubMed ID: 7026020
[TBL] [Abstract][Full Text] [Related]
16. Cyclical combination chemotherapy in advanced breast cancer.
Edelstyn GA; Marcrae KD
Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
[No Abstract] [Full Text] [Related]
17. [Advanced carcinoma of the breast. Results of a polychemotherapeutic protocol].
Fazio M; Manca A; Rodino A; Cavallero P; Tripodina A
Minerva Ginecol; 1982 Sep; 34(9):667-70. PubMed ID: 7145204
[No Abstract] [Full Text] [Related]
18. Five-drug therapy in advanced breast cancer: factors influencing toxicity and response.
Davis HL; Ramirez G; Ellerby RA; Ansfield FJ
Cancer; 1974 Aug; 34(2):239-45. PubMed ID: 4852055
[No Abstract] [Full Text] [Related]
19. Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432.
Watanabe Y; Iwa T
Cancer; 1984 Jan; 53(2):248-53. PubMed ID: 6690008
[TBL] [Abstract][Full Text] [Related]
20. Clinical studies on the combined immunochemotherapy with a streptococcal preparation (Picibanil) and other anticancer drugs.
Misawa S; Sawai K; Takino T; Masuda M; Abe T; Kawai K
Nihon Gan Chiryo Gakkai Shi; 1979 Jun; 14(3):291-305. PubMed ID: 479655
[No Abstract] [Full Text] [Related]
[Next] [New Search]
